Blog

In an exciting breakthrough, researchers at Johns Hopkins Medicine have unveiled an experimental synthetic mRNA platform that could significantly accelerate the development of therapies for...

Navigating the complexities of cancer treatment and support can be overwhelming for patients and their families. With countless organizations dedicated to providing resources, emotional support, and...

Recent research has sparked a critical conversation in the oncology community about the dosages of cancer drugs, particularly immunotherapies like Keytruda and Opdivo. As reported by KFF Health News,...

Cancer patients face an immense number of challenges on their journey to recovery, not just the disease itself but also a myriad of health complications that arise from the treatment. As highlighted...

Navigating the landscape of cancer research can be an overwhelming task. With a wealth of information available—from clinical trials and research papers to the latest oncology news—patients,...

The FDA Approvals API is a powerful endpoint within the free Cure Cancer With AI API that provides a structured feed of FDA-approved oncology drugs. This endpoint is crucial for researchers,...

In a groundbreaking series of papers published in the journal Genes & Development , scientists led by Dr. Anindya Bagchi have unveiled a unified framework that identifies a master regulator of cancer...

The recent discovery by researchers at the Johns Hopkins Kimmel Cancer Center that bacteria present in lung tumors may enhance the immune response to cancer is a significant breakthrough in cancer...

At Cure Cancer With AI , our mission is to empower individuals with knowledge and resources about cancer research and treatment options. We strive to provide the latest developments in cancer...

In a groundbreaking study, researchers at Washington University School of Medicine have identified previously unknown immune structures within the skull of mice that could revolutionize how we...

Recent research from the Washington University School of Medicine has unveiled a groundbreaking discovery that could reshape our understanding of brain cancer and its treatment. The identification of...

Navigating the complex world of cancer research, clinical trials, and ongoing medical developments can be overwhelming for patients, caregivers, and advocates. With thousands of research papers...

In a significant advancement for pediatric oncology, researchers at Children's Hospital Los Angeles have unveiled a clinical decision tool designed to optimize thiopurine therapy for children...

The recent recognition of the UC Davis Comprehensive Cancer Center by the National Cancer Institute (NCI) as one of the top cancer centers in the United States, coupled with a significant grant of...

Cancer research is a rapidly evolving field, with new studies, clinical trials, and treatment options emerging almost daily. For patients, caregivers, advocates, and those interested in oncology...

The recent announcement that the UC Davis Comprehensive Cancer Center has been awarded renewed “comprehensive” designation by the National Cancer Institute (NCI) is a significant milestone in the...

Recent research has shed light on hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, revealing how certain gene signatures associated with fat storage may classify this disease...

Cancer research is a rapidly evolving field, with new studies, clinical trials, and treatment options emerging almost daily. For patients, caregivers, advocates, and research-minded individuals,...

In a groundbreaking study, researchers have discovered that red blood cells (RBCs), the oxygen-carrying cells in our blood, can be transformed into therapeutic nanocarriers. This innovation opens up...

The recent discovery that red blood cells can be repurposed as nanocarriers for targeted drug delivery marks a significant advancement in cancer research and treatment innovation. This breakthrough...